Meet the Team

Seroxo has a highly experienced and technical team with experience of landmark biotech exit.

    • 25 years’ experience in industry; DPhil in biomedical engineering from University of Oxford

    • Previous co-founder of PowderJect (acquired by Chiron for $879M)

    • Former CEO of The Acrobot Company and Executive Advisor for BioExec Ventures

    • Over 30 years operating at the level of Finance Director/CFO within the life science sector, including Cephalon Inc (NASDAQ, €500m turnover) – Acquired by Teva for $6.2B

    • Practicing General Practitioner; MBA from Imperial Business School

    • He advises healthcare technology startups

Clinical Advisory Board

Seroxo works with world class professionals in the field of immunology, cancer and infectious disease.

  • Consultant Ear Nose and Throat Surgeon, Oxford University Hospital NHS trust

    • Consultant Ear Nose and Throat Surgeon since

    • Lead consultant at the Oxford Head and Neck Unit at the Oxford University Hospitals NHS Trust

  • Head of Infectious Diseases, University of Oxford

    • Head of Infectious Diseases Unit at the Churchill Hospital, University of Oxford

    • Head of Experimental Medicine, University of Oxford

  • Breast and Oncoplastic Surgeon, Oxford University Hospital NHS trust

    • Consultant breast and oncoplastic surgeon

    • She is the senior Oncoplastic Breast Surgeon at Oxford University Hospitals and provides private consultations at Nuffield Health, The Manor Hospital and GenesisCare in Oxford

  • Professor of Haematology, University of Birmingham

    • An international figure in translational human immunology & NIHR Senior Investigator

    • Currently leading the UK Coronavirus Immunology Consortium (UK-CIC)

    • Previously Chair of Infection & Immunity Board at Medical Research Council (MRC)

    • Also served as Chair of Clinical & Translational Res Comm at Cancer Research UK